Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression
<p>Abstract</p> <p>Background</p> <p>Prevention of bladder cancer recurrence is a central challenge in the management of this highly prevalent disease. The histone deacetylase inhibitor valproic acid (sodium valproate) has anti-angiogenic properties and has been shown t...
Main Authors: | Byler Timothy K, Leocadio Dean, Shapiro Oleg, Bratslavsky Gennady, Stodgell Christopher J, Wood Ronald W, Messing Edward M, Reeder Jay E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | BMC Urology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2490/12/21 |
Similar Items
-
An epidemiologic study on urothelial carcinomas of bladder
by: Ayşenur Keleş, et al.
Published: (2011-09-01) -
The Evaluation of Thrombospondin 1 Levels in Patients with Acromegaly
by: Mustafa Demirpençe, et al.
Published: (2020-01-01) -
Chemotherapy of Locally Advanced or Metastatic Urothelial Cell Carcinoma: Monocentric Real-Life Data
by: Fischer C, et al.
Published: (2020-06-01) -
Plasmacytoid Urothelial Carcinoma of the Bladder: Case Report and Review of the Literature
by: Ángela Molina Barrera, et al.
Published: (2019-02-01) -
Thrombospondin expression in myofibers stabilizes muscle membranes
by: Davy Vanhoutte, et al.
Published: (2016-09-01)